Shopping Cart
- Remove All
Your shopping cart is currently empty
α-Glucosidase-IN-21 (Compound 2B) is a highly potent, orally bioavailable α-glucosidase inhibitor with an IC50 value of 2.62 μM, demonstrating remarkable anti-diabetic properties [1].

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 25 mg | $1,520 | 6-8 weeks | |
| 50 mg | $1,980 | 6-8 weeks | |
| 100 mg | $2,500 | 6-8 weeks |
| Description | α-Glucosidase-IN-21 (Compound 2B) is a highly potent, orally bioavailable α-glucosidase inhibitor with an IC50 value of 2.62 μM, demonstrating remarkable anti-diabetic properties [1]. |
| In vivo | α-Glucosidase-IN-21 (Compound 2B), administered orally at 10 and 20 mg/kg daily for four weeks, demonstrates anti-diabetic efficacy in male Wistar albino rats (170-200 g) with Streptozocin-induced diabetes. This compound significantly reduces serum glucose levels post-glucose administration (3 g/kg, orally) and shows no mortality in mice at 2000 mg/kg over two weeks. In addition, α-Glucosidase-IN-21 effectively decreases blood glucose levels, counteracts Streptozocin-induced weight loss, and exhibits antihyperlipidemic properties by notably lowering serum biomarkers in the diabetic rat model. |
| Molecular Weight | 389.51 |
| Formula | C24H23NO2S |
| Cas No. | 321686-01-5 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.